JP2025506419A5 - - Google Patents
Info
- Publication number
- JP2025506419A5 JP2025506419A5 JP2024546193A JP2024546193A JP2025506419A5 JP 2025506419 A5 JP2025506419 A5 JP 2025506419A5 JP 2024546193 A JP2024546193 A JP 2024546193A JP 2024546193 A JP2024546193 A JP 2024546193A JP 2025506419 A5 JP2025506419 A5 JP 2025506419A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263306928P | 2022-02-04 | 2022-02-04 | |
| US202263306941P | 2022-02-04 | 2022-02-04 | |
| US63/306,928 | 2022-02-04 | ||
| US63/306,941 | 2022-02-04 | ||
| PCT/US2023/061953 WO2023150689A2 (en) | 2022-02-04 | 2023-02-03 | Gjb2 regulatory elements and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025506419A JP2025506419A (ja) | 2025-03-11 |
| JPWO2023150689A5 JPWO2023150689A5 (https=) | 2026-02-04 |
| JP2025506419A5 true JP2025506419A5 (https=) | 2026-02-04 |
Family
ID=87552983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024546193A Pending JP2025506419A (ja) | 2022-02-04 | 2023-02-03 | Ｇｊｂ２調節エレメント及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250127928A1 (https=) |
| EP (1) | EP4473005A4 (https=) |
| JP (1) | JP2025506419A (https=) |
| KR (1) | KR20240156606A (https=) |
| AU (1) | AU2023214481A1 (https=) |
| CA (1) | CA3250345A1 (https=) |
| CL (1) | CL2024002306A1 (https=) |
| CO (1) | CO2024012057A2 (https=) |
| IL (1) | IL314705A (https=) |
| MX (1) | MX2024009520A (https=) |
| WO (1) | WO2023150689A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026025095A2 (en) | 2024-07-26 | 2026-01-29 | Regeneron Pharmaceuticals, Inc. | Otic drug delivery system and methods |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3159549A1 (en) * | 2019-10-30 | 2021-05-06 | Decibel Therapeutics, Inc. | Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems |
| EP4164695A4 (en) * | 2020-05-13 | 2024-06-05 | Akouos, Inc. | COMPOSITIONS AND METHODS FOR TREATING GJB2-ASSOCIATED HEARING LOSS |
-
2023
- 2023-02-03 CA CA3250345A patent/CA3250345A1/en active Pending
- 2023-02-03 AU AU2023214481A patent/AU2023214481A1/en active Pending
- 2023-02-03 IL IL314705A patent/IL314705A/en unknown
- 2023-02-03 MX MX2024009520A patent/MX2024009520A/es unknown
- 2023-02-03 EP EP23750443.6A patent/EP4473005A4/en active Pending
- 2023-02-03 US US18/835,452 patent/US20250127928A1/en active Pending
- 2023-02-03 WO PCT/US2023/061953 patent/WO2023150689A2/en not_active Ceased
- 2023-02-03 KR KR1020247029441A patent/KR20240156606A/ko active Pending
- 2023-02-03 JP JP2024546193A patent/JP2025506419A/ja active Pending
-
2024
- 2024-07-31 CL CL2024002306A patent/CL2024002306A1/es unknown
- 2024-09-04 CO CONC2024/0012057A patent/CO2024012057A2/es unknown